aluates Reports

$ 0.0

Automative

Global Narcotic (Opioid) Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-25X1813

Global Narcotic Opioid Drugs Market Insights Forecast to 2028

BUY CHAPTERS

Global Narcotic (Opioid) Drugs Market Research Report 2025

Code: QYRE-Auto-25X1813

Report

July 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

TEVA

Purdue Pharma

Mallinckrodt plc

Amneal Pharma

Collegium

Johnson & Johnson

Merck

Mylan NV

Hikma Pharmaceuticals

Sun Pharma

Endo Pharmaceuticals

Allergan plc

Narcotic (Opioid) Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Narcotic (Opioid) Drugs Market

The global market for Narcotic (Opioid) Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Narcotic (Opioid) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Narcotic (Opioid) Drugs.

The Narcotic (Opioid) Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Narcotic (Opioid) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Narcotic (Opioid) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Narcotic (Opioid) Drugs Market Report

Report Metric	Details
Report Name	Narcotic (Opioid) Drugs Market
CAGR	5%
Segment by Type	Codeine Fentanyl Hydrocodone Hydromorphone Meperidine Methadone Others
Segment by Application	Pain Relief Application Anesthesia Application
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, Johnson & Johnson, Merck, Mylan, Hikma Pharmaceuticals, Sun Pharma, Endo Pharmaceuticals, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Narcotic (Opioid) Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Narcotic (Opioid) Drugs Market report?

Ans: The main players in the Narcotic (Opioid) Drugs Market are Pfizer, Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, Johnson & Johnson, Merck, Mylan, Hikma Pharmaceuticals, Sun Pharma, Endo Pharmaceuticals, Allergan

What are the Application segmentation covered in the Narcotic (Opioid) Drugs Market report?

Ans: The Applications covered in the Narcotic (Opioid) Drugs Market report are Pain Relief Application, Anesthesia Application

What are the Type segmentation covered in the Narcotic (Opioid) Drugs Market report?

Ans: The Types covered in the Narcotic (Opioid) Drugs Market report are Codeine, Fentanyl, Hydrocodone, Hydromorphone, Meperidine, Methadone, Others

Recommended Reports

Pain Relief Markets

Opioid & Abuse Drugs

Sleep & Anesthetics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Codeine

1.2.3 Fentanyl

1.2.4 Hydrocodone

1.2.5 Hydromorphone

1.2.6 Meperidine

1.2.7 Methadone

1.2.8 Others

1.3 Market by Application

1.3.1 Global Narcotic (Opioid) Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pain Relief Application

1.3.3 Anesthesia Application

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Narcotic (Opioid) Drugs Market Perspective (2020-2031)

2.2 Global Narcotic (Opioid) Drugs Growth Trends by Region

2.2.1 Global Narcotic (Opioid) Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Narcotic (Opioid) Drugs Historic Market Size by Region (2020-2025)

2.2.3 Narcotic (Opioid) Drugs Forecasted Market Size by Region (2026-2031)

2.3 Narcotic (Opioid) Drugs Market Dynamics

2.3.1 Narcotic (Opioid) Drugs Industry Trends

2.3.2 Narcotic (Opioid) Drugs Market Drivers

2.3.3 Narcotic (Opioid) Drugs Market Challenges

2.3.4 Narcotic (Opioid) Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Narcotic (Opioid) Drugs Players by Revenue

3.1.1 Global Top Narcotic (Opioid) Drugs Players by Revenue (2020-2025)

3.1.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Narcotic (Opioid) Drugs Revenue

3.4 Global Narcotic (Opioid) Drugs Market Concentration Ratio

3.4.1 Global Narcotic (Opioid) Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Narcotic (Opioid) Drugs Revenue in 2024

3.5 Global Key Players of Narcotic (Opioid) Drugs Head office and Area Served

3.6 Global Key Players of Narcotic (Opioid) Drugs, Product and Application

3.7 Global Key Players of Narcotic (Opioid) Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Narcotic (Opioid) Drugs Breakdown Data by Type

4.1 Global Narcotic (Opioid) Drugs Historic Market Size by Type (2020-2025)

4.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2026-2031)

5 Narcotic (Opioid) Drugs Breakdown Data by Application

5.1 Global Narcotic (Opioid) Drugs Historic Market Size by Application (2020-2025)

5.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Narcotic (Opioid) Drugs Market Size (2020-2031)

6.2 North America Narcotic (Opioid) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Narcotic (Opioid) Drugs Market Size by Country (2020-2025)

6.4 North America Narcotic (Opioid) Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Narcotic (Opioid) Drugs Market Size (2020-2031)

7.2 Europe Narcotic (Opioid) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Narcotic (Opioid) Drugs Market Size by Country (2020-2025)

7.4 Europe Narcotic (Opioid) Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size (2020-2031)

8.2 Asia-Pacific Narcotic (Opioid) Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Narcotic (Opioid) Drugs Market Size (2020-2031)

9.2 Latin America Narcotic (Opioid) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Narcotic (Opioid) Drugs Market Size by Country (2020-2025)

9.4 Latin America Narcotic (Opioid) Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size (2020-2031)

10.2 Middle East & Africa Narcotic (Opioid) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Narcotic (Opioid) Drugs Introduction

11.1.4 Pfizer Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Teva

11.2.1 Teva Company Details

11.2.2 Teva Business Overview

11.2.3 Teva Narcotic (Opioid) Drugs Introduction

11.2.4 Teva Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.2.5 Teva Recent Development

11.3 Purdue Pharma

11.3.1 Purdue Pharma Company Details

11.3.2 Purdue Pharma Business Overview

11.3.3 Purdue Pharma Narcotic (Opioid) Drugs Introduction

11.3.4 Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.3.5 Purdue Pharma Recent Development

11.4 Mallinckrodt

11.4.1 Mallinckrodt Company Details

11.4.2 Mallinckrodt Business Overview

11.4.3 Mallinckrodt Narcotic (Opioid) Drugs Introduction

11.4.4 Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.4.5 Mallinckrodt Recent Development

11.5 Amneal Pharma

11.5.1 Amneal Pharma Company Details

11.5.2 Amneal Pharma Business Overview

11.5.3 Amneal Pharma Narcotic (Opioid) Drugs Introduction

11.5.4 Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.5.5 Amneal Pharma Recent Development

11.6 Collegium

11.6.1 Collegium Company Details

11.6.2 Collegium Business Overview

11.6.3 Collegium Narcotic (Opioid) Drugs Introduction

11.6.4 Collegium Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.6.5 Collegium Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Details

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Introduction

11.7.4 Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.7.5 Johnson & Johnson Recent Development

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Narcotic (Opioid) Drugs Introduction

11.8.4 Merck Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.8.5 Merck Recent Development

11.9 Mylan

11.9.1 Mylan Company Details

11.9.2 Mylan Business Overview

11.9.3 Mylan Narcotic (Opioid) Drugs Introduction

11.9.4 Mylan Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.9.5 Mylan Recent Development

11.10 Hikma Pharmaceuticals

11.10.1 Hikma Pharmaceuticals Company Details

11.10.2 Hikma Pharmaceuticals Business Overview

11.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Introduction

11.10.4 Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.10.5 Hikma Pharmaceuticals Recent Development

11.11 Sun Pharma

11.11.1 Sun Pharma Company Details

11.11.2 Sun Pharma Business Overview

11.11.3 Sun Pharma Narcotic (Opioid) Drugs Introduction

11.11.4 Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.11.5 Sun Pharma Recent Development

11.12 Endo Pharmaceuticals

11.12.1 Endo Pharmaceuticals Company Details

11.12.2 Endo Pharmaceuticals Business Overview

11.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Introduction

11.12.4 Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.12.5 Endo Pharmaceuticals Recent Development

11.13 Allergan

11.13.1 Allergan Company Details

11.13.2 Allergan Business Overview

11.13.3 Allergan Narcotic (Opioid) Drugs Introduction

11.13.4 Allergan Revenue in Narcotic (Opioid) Drugs Business (2020-2025)

11.13.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

TEVA

Purdue Pharma

Mallinckrodt plc

Amneal Pharma

Collegium

Johnson & Johnson

Merck

Mylan NV

Hikma Pharmaceuticals

Sun Pharma

Endo Pharmaceuticals

Allergan plc

List of Tables

Table 1. Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Codeine

Table 3. Key Players of Fentanyl

Table 4. Key Players of Hydrocodone

Table 5. Key Players of Hydromorphone

Table 6. Key Players of Meperidine

Table 7. Key Players of Methadone

Table 8. Key Players of Others

Table 9. Global Narcotic (Opioid) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Narcotic (Opioid) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Narcotic (Opioid) Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Narcotic (Opioid) Drugs Market Share by Region (2020-2025)

Table 13. Global Narcotic (Opioid) Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Narcotic (Opioid) Drugs Market Share by Region (2026-2031)

Table 15. Narcotic (Opioid) Drugs Market Trends

Table 16. Narcotic (Opioid) Drugs Market Drivers

Table 17. Narcotic (Opioid) Drugs Market Challenges

Table 18. Narcotic (Opioid) Drugs Market Restraints

Table 19. Global Narcotic (Opioid) Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Narcotic (Opioid) Drugs Market Share by Players (2020-2025)

Table 21. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2024)

Table 22. Ranking of Global Top Narcotic (Opioid) Drugs Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Narcotic (Opioid) Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Narcotic (Opioid) Drugs, Headquarters and Area Served

Table 25. Global Key Players of Narcotic (Opioid) Drugs, Product and Application

Table 26. Global Key Players of Narcotic (Opioid) Drugs, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Narcotic (Opioid) Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2020-2025)

Table 30. Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2026-2031)

Table 32. Global Narcotic (Opioid) Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2020-2025)

Table 34. Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2026-2031)

Table 36. North America Narcotic (Opioid) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Narcotic (Opioid) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Narcotic (Opioid) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Narcotic (Opioid) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Narcotic (Opioid) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Narcotic (Opioid) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Narcotic (Opioid) Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Narcotic (Opioid) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Narcotic (Opioid) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Narcotic (Opioid) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Narcotic (Opioid) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer Narcotic (Opioid) Drugs Product

Table 54. Pfizer Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. Teva Company Details

Table 57. Teva Business Overview

Table 58. Teva Narcotic (Opioid) Drugs Product

Table 59. Teva Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 60. Teva Recent Development

Table 61. Purdue Pharma Company Details

Table 62. Purdue Pharma Business Overview

Table 63. Purdue Pharma Narcotic (Opioid) Drugs Product

Table 64. Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 65. Purdue Pharma Recent Development

Table 66. Mallinckrodt Company Details

Table 67. Mallinckrodt Business Overview

Table 68. Mallinckrodt Narcotic (Opioid) Drugs Product

Table 69. Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 70. Mallinckrodt Recent Development

Table 71. Amneal Pharma Company Details

Table 72. Amneal Pharma Business Overview

Table 73. Amneal Pharma Narcotic (Opioid) Drugs Product

Table 74. Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 75. Amneal Pharma Recent Development

Table 76. Collegium Company Details

Table 77. Collegium Business Overview

Table 78. Collegium Narcotic (Opioid) Drugs Product

Table 79. Collegium Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 80. Collegium Recent Development

Table 81. Johnson & Johnson Company Details

Table 82. Johnson & Johnson Business Overview

Table 83. Johnson & Johnson Narcotic (Opioid) Drugs Product

Table 84. Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 85. Johnson & Johnson Recent Development

Table 86. Merck Company Details

Table 87. Merck Business Overview

Table 88. Merck Narcotic (Opioid) Drugs Product

Table 89. Merck Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 90. Merck Recent Development

Table 91. Mylan Company Details

Table 92. Mylan Business Overview

Table 93. Mylan Narcotic (Opioid) Drugs Product

Table 94. Mylan Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 95. Mylan Recent Development

Table 96. Hikma Pharmaceuticals Company Details

Table 97. Hikma Pharmaceuticals Business Overview

Table 98. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product

Table 99. Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 100. Hikma Pharmaceuticals Recent Development

Table 101. Sun Pharma Company Details

Table 102. Sun Pharma Business Overview

Table 103. Sun Pharma Narcotic (Opioid) Drugs Product

Table 104. Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 105. Sun Pharma Recent Development

Table 106. Endo Pharmaceuticals Company Details

Table 107. Endo Pharmaceuticals Business Overview

Table 108. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product

Table 109. Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 110. Endo Pharmaceuticals Recent Development

Table 111. Allergan Company Details

Table 112. Allergan Business Overview

Table 113. Allergan Narcotic (Opioid) Drugs Product

Table 114. Allergan Revenue in Narcotic (Opioid) Drugs Business (2020-2025) & (US$ Million)

Table 115. Allergan Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Narcotic (Opioid) Drugs Picture

Figure 2. Global Narcotic (Opioid) Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Narcotic (Opioid) Drugs Market Share by Type: 2024 VS 2031

Figure 4. Codeine Features

Figure 5. Fentanyl Features

Figure 6. Hydrocodone Features

Figure 7. Hydromorphone Features

Figure 8. Meperidine Features

Figure 9. Methadone Features

Figure 10. Others Features

Figure 11. Global Narcotic (Opioid) Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Narcotic (Opioid) Drugs Market Share by Application: 2024 VS 2031

Figure 13. Pain Relief Application Case Studies

Figure 14. Anesthesia Application Case Studies

Figure 15. Narcotic (Opioid) Drugs Report Years Considered

Figure 16. Global Narcotic (Opioid) Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Narcotic (Opioid) Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Narcotic (Opioid) Drugs Market Share by Region: 2024 VS 2031

Figure 19. Global Narcotic (Opioid) Drugs Market Share by Players in 2024

Figure 20. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Narcotic (Opioid) Drugs Revenue in 2024

Figure 22. North America Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Narcotic (Opioid) Drugs Market Share by Country (2020-2031)

Figure 24. United States Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Narcotic (Opioid) Drugs Market Share by Country (2020-2031)

Figure 28. Germany Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Region (2020-2031)

Figure 36. China Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Narcotic (Opioid) Drugs Market Share by Country (2020-2031)

Figure 44. Mexico Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Narcotic (Opioid) Drugs Market Share by Country (2020-2031)

Figure 48. Turkey Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Narcotic (Opioid) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Pfizer Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 52. Teva Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 53. Purdue Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 54. Mallinckrodt Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 55. Amneal Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 56. Collegium Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 57. Johnson & Johnson Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 58. Merck Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 59. Mylan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 60. Hikma Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 61. Sun Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 62. Endo Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 63. Allergan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Opioids Drug Market Research Report 2025

Opioids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Pain Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Opioid Narcotics Market Research Report 2024

Opioid Withdrawal Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Powerful Analgesics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Morphine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Narcotic Analgesics Market Research Report 2025

Global Opioid Analgesics Market Research Report 2025

Global Opioid Use Disorder Treatment Market Research Report 2024

Global Opioid Use Disorder Market Insights Forecast to 2030

Opioid Dependence Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global OTC Pain Medications Market Research Report 2024

Naloxone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non opioid Analgesics Market Research Report 2024

Global Narcotic Analgesics Market Research Report 2025

Pain Management Product Market

Global Opioid Withdrawal Syndrome Market Research Report 2024

Global Nonnarcotic Analgesics Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions